1. Home
  2. VATE vs CLNN Comparison

VATE vs CLNN Comparison

Compare VATE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.59

Market Cap

74.0M

Sector

Industrials

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$4.61

Market Cap

69.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VATE
CLNN
Founded
1994
2012
Country
United States
United States
Employees
N/A
76
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
74.0M
69.7M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VATE
CLNN
Price
$4.59
$4.61
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$32.67
AVG Volume (30 Days)
12.1K
66.3K
Earning Date
03-26-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,246,000,000.00
N/A
Revenue This Year
N/A
$12.20
Revenue Next Year
N/A
$20,465.06
P/E Ratio
N/A
N/A
Revenue Growth
12.55
N/A
52 Week Low
$3.75
$2.28
52 Week High
$8.28
$13.50

Technical Indicators

Market Signals
Indicator
VATE
CLNN
Relative Strength Index (RSI) 49.67 39.49
Support Level $4.31 $4.50
Resistance Level $5.52 $6.83
Average True Range (ATR) 0.36 0.61
MACD 0.02 -0.12
Stochastic Oscillator 60.77 0.13

Price Performance

Historical Comparison
VATE
CLNN

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: